drugset / Trial / NCT02598622

A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL

NCT02598622

Phase 2 Terminated 8 enrolled Indiana University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to see if a drug called Acetyl-L-Carnitine can help prevent painful nerve damage and nerve pain which is caused by vincristine, a drug used in chemotherapy in children being treated for newly diagnosed ALL. Acetyl-L-Carnitine is a drug available for purchase as a nutritional supplement but for the purpose of this study is experimental.

Timeline

Start
2009-09
Primary completion
2012-05
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule